Wednesday September 27, 2017 01:04

Heathcare Press Release : 29 Aug 2017

Photo Release: Better vision for the poor Heathcare—29 Aug 17

Dr. Sukanda Swasdibutra, a refractive surgery specialist at TRSC International LASIK Center accepted the donation of new eye glasses from Khun Siritorn Greewong, the owner of M.S. Gems on behalf of TRSC International LASIK Center. The new eye glasses

Victoza(R) Reduces the Risk of Major Cardiovascular Events in People with Type 2 Diabetes With or Without Prior Events Heathcare—29 Aug 17

BARCELONA, Spain--29 Aug--PRNewswire/InfoQuest
Oral Presentation 3909

A new analysis of the landmark LEADER trial shows that Victoza(R) (liraglutide) reduced the risk of major cardiovascular (CV) events in people with type 2 diabetes at high CV risk, irrespective of their history of having a heart attack and/or stroke or not having any of these events, when compared to placebo.[1] This post-hoc analysis was presented today at the European Society of Cardiology (ESC) Annual Congress in Barcelona, Spain.

Cardiovascular disease is the leading cause of morbidity and mortality in people with diabetes.[2] Furthermore, studies have shown that adults with type 2 diabetes have up to a four times greater risk of heart attack and stroke.[3]

"This new analysis expands our understanding of the benefits of Victoza(R) in reducing cardiovascular risk in people with type 2 diabetes," said Professor Neil Poulter, on behalf of the LEADER Trial Steering Committee and Investigators. "These encouraging results are consistent with the cardiovascular benefits of Victoza(R) observed in LEADER in both people with a history of having a heart attack and/or stroke as well as people at high risk without prior history of these types of cardiovascular events."

Victoza(R) reduced the risk of major CV events (non-fatal heart attack, non-

FDI Releases Chairside Guide for Dentists with a Focus on Caries Prevention Heathcare—29 Aug 17

FDI World Dental Federation issued today a chairside guide to advise clinicians on restorative interventions with their patients. It was released on the opening day of the FDI World Dental Congress in Madrid, Spain (29 August-1 September) under the